Since AD associates with increased activation of GFAP+ astrocytes and Iba‐1+ microglia and their migration into the DG,[7, 8] these data show that CRB‐2131 suppresses hippocampal AD‐related neuroinflammation. The gene discussed is GFAP; the disease is Alzheimer disease.